WHO revises COVID-19 vaccine recommendations for Omicron-eraTherapeuticsToday the World Health Organization changed its recommendations for COVID-19 vaccines, suggesting that high-risk populations should receive an additional dose 12 months after their last booster. Read more March 28, 2023/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2021/04/WHO-says-AstraZeneca-benefits-outweigh-risks-assessing-latest-data-Reuters-4-6-21.jpeg 253 370 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2023-03-28 09:55:332023-03-28 11:00:03WHO revises COVID-19 vaccine recommendations for Omicron-era
